{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:50:49Z","timestamp":1787698249517,"version":"build-2784847793"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1176553"],"award-info":[{"award-number":["APP1176553"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.smim.2025.101960","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T22:33:34Z","timestamp":1745447614000},"page":"101960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Immune therapies in coeliac disease and food allergies: Advances, challenges, and opportunities"],"prefix":"10.1016","volume":"78","author":[{"given":"Dianne E.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Mehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia G.","family":"Moscatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7687-9654","authenticated-orcid":false,"given":"Jason A.","family":"Tye-Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2025.101960_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-pathmechdis-031521-032634","article-title":"The immunobiology and pathogenesis of celiac disease","volume":"18","author":"Iversen","year":"2023","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.smim.2025.101960_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.gastro.2024.03.042","article-title":"New insights on genes, gluten, and immunopathogenesis of celiac disease","volume":"167","author":"Abadie","year":"2024","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.smim.2025.101960_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jgh.13703","article-title":"What is gluten?","volume":"32","author":"Biesiekierski","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.smim.2025.101960_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.cgh.2007.10.012","article-title":"Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment","volume":"6","author":"Murray","year":"2008","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.smim.2025.101960_bib5","first-page":"51","article-title":"Clinical presentation and spectrum of gluten symptomatology in celiac disease","volume":"167","author":"Adams","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2025.101960_bib6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","article-title":"Global prevalence of celiac disease: systematic review and meta-analysis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.smim.2025.101960_bib7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/apt.17803","article-title":"Trends in the prevalence rates and predictive factors of coeliac disease: a long-term nationwide follow-up study","volume":"59","author":"Taavela","year":"2024","journal-title":"Aliment Pharm. Ther."},{"key":"10.1016\/j.smim.2025.101960_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-323-37579-5.00001-5","article-title":"Chapter 1 - Introduction to Mechanisms of Allergic Diseases","author":"Kubo","year":"2017","journal-title":"Middleton's Allergy Essentials"},{"key":"10.1016\/j.smim.2025.101960_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/1939-4551-6-21","article-title":"A global survey of changing patterns of food allergy burden in children","volume":"6","author":"Prescott","year":"2013","journal-title":"World Allergy Organ J."},{"key":"10.1016\/j.smim.2025.101960_bib10","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/all.12423","article-title":"Prevalence of common food allergies in Europe: a systematic review and meta-analysis","volume":"69","author":"Nwaru","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.smim.2025.101960_bib11","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jaip.2024.03.015","article-title":"The prevalence of IgE-mediated food allergy and other allergic diseases in the first 10 years: the population-based, longitudinal HealthNuts study","volume":"12","author":"Peters","year":"2024","journal-title":"J. Allergy Clin. Immunol. Pr."},{"key":"10.1016\/j.smim.2025.101960_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.5630","article-title":"Prevalence and severity of food allergies among US adults","volume":"2","author":"Gupta","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.smim.2025.101960_bib13","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-1235","article-title":"The public health impact of parent-reported childhood food allergies in the United States","volume":"142","author":"Gupta","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.smim.2025.101960_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/all.15560","article-title":"Frequency of food allergy in Europe: an updated systematic review and meta-analysis","volume":"78","author":"Spolidoro","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.smim.2025.101960_bib15","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1111\/all.15902","article-title":"EAACI guidelines on the diagnosis of IgE-mediated food allergy","volume":"78","author":"Santos","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.smim.2025.101960_bib16","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jaci.2014.05.013","article-title":"Food allergy: a practice parameter update-2014","volume":"134","author":"Sampson","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib17","doi-asserted-by":"crossref","first-page":"n251","DOI":"10.1136\/bmj.n251","article-title":"Food anaphylaxis in the United Kingdom: analysis of national data, 1998-2018","volume":"372","author":"Baseggio Conrado","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.smim.2025.101960_bib18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/pai.12908","article-title":"National trends in emergency department visits and hospitalizations for food-induced anaphylaxis in US children","volume":"29","author":"Motosue","year":"2018","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaci.2021.12.795","article-title":"Changes in Australian food anaphylaxis admission rates following introduction of updated allergy prevention guidelines","volume":"150","author":"Mullins","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw7756","article-title":"Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease","volume":"5","author":"Goel","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.smim.2025.101960_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/73200","article-title":"In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope","volume":"6","author":"Anderson","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2025.101960_bib22","doi-asserted-by":"crossref","first-page":"13073","DOI":"10.1073\/pnas.1311861110","article-title":"Dietary gluten triggers concomitant activation of CD4+ and CD8+ alphabeta T cells and gammadelta T cells in celiac disease","volume":"110","author":"Han","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2025.101960_bib23","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/j.gastro.2020.10.040","article-title":"Evaluating responses to gluten challenge: a randomized, double-blind, 2-dose gluten challenge trial","volume":"160","author":"Leonard","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2025.101960_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2036.2009.04053.x","article-title":"Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease","volume":"30","author":"Hall","year":"2009","journal-title":"Aliment Pharm. Ther."},{"key":"10.1016\/j.smim.2025.101960_bib25","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ajg.2014.29","article-title":"Patient perception of treatment burden is high in celiac disease compared with other common conditions","volume":"109","author":"Shah","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.smim.2025.101960_bib26","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1053\/j.gastro.2019.12.016","article-title":"Most patients with celiac disease on gluten-free diets consume measurable amounts of gluten","volume":"158","author":"Silvester","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2025.101960_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/nu16020279","article-title":"Stool gluten peptide detection is superior to urinary analysis, coeliac serology, dietary adherence scores and symptoms in the detection of intermittent gluten exposure in coeliac disease: a randomised, placebo-controlled, low-dose gluten challenge study","volume":"16","author":"Russell","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.smim.2025.101960_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000371","article-title":"Association between coeliac disease and cardiovascular disease: prospective analysis of UK Biobank data","volume":"2","author":"Conroy","year":"2023","journal-title":"BMJ Med"},{"key":"10.1016\/j.smim.2025.101960_bib29","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/liv.14767","article-title":"Metabolic-associated fatty liver disease (MAFLD) in coeliac disease","volume":"41","author":"Rispo","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.smim.2025.101960_bib30","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/jgh.14039","article-title":"Effect of the gluten-free diet on cardiovascular risk factors in patients with coeliac disease: a systematic review","volume":"33","author":"Potter","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.smim.2025.101960_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1471-230X-11-129","article-title":"Small- bowel mucosal changes and antibody responses after low- and moderate-dose gluten challenge in celiac disease","volume":"11","author":"Lahdeaho","year":"2011","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.smim.2025.101960_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076163","article-title":"Validation of morphometric analyses of small-intestinal biopsy readouts in celiac disease","volume":"8","author":"Taavela","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2025.101960_bib33","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/s41590-024-01867-0","article-title":"Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease","volume":"25","author":"Dotsenko","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib34","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cgh.2024.08.005","article-title":"Biopsy proteome score performs well as an effect measure in a gluten challenge trial of celiac disease","volume":"23","author":"Johansen","year":"2025","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.smim.2025.101960_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/j.gastro.2024.01.053","article-title":"Past, present, and future of noninvasive tests to assess gluten exposure, celiac disease activity, and end-organ damage","volume":"167","author":"Silvester","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2025.101960_bib36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ajcn\/85.1.160","article-title":"A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease","volume":"85","author":"Catassi","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.smim.2025.101960_bib37","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/ajcn\/86.1.260","article-title":"Safe gluten threshold for patients with celiac disease: some patients are more tolerant than others","volume":"86","author":"Collin","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.smim.2025.101960_bib38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12916-020-01828-y","article-title":"Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease","volume":"18","author":"Tye-Din","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.smim.2025.101960_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111831","article-title":"Full range of population Eliciting Dose values for 14 priority allergenic foods and recommendations for use in risk characterization","volume":"146","author":"Houben","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.smim.2025.101960_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111259","article-title":"Updated population minimal eliciting dose distributions for use in risk assessment of 14 priority food allergens","volume":"139","author":"Remington","year":"2020","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.smim.2025.101960_bib42","first-page":"S49","article-title":"Review article: Follow-up of coeliac disease","volume":"56","author":"Tye-Din","year":"2022","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.smim.2025.101960_bib43","first-page":"132","article-title":"Advances in nonresponsive and refractory celiac disease","volume":"167","author":"Malamut","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2025.101960_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/nu12010216","article-title":"Non-Responsive coeliac disease: a comprehensive review from the NHS England National Centre for Refractory Coeliac Disease","volume":"12","author":"Penny","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.smim.2025.101960_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ygh2.380","article-title":"Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten-free diet","volume":"2","author":"Daveson","year":"2020","journal-title":"GastroHep"},{"key":"10.1016\/j.smim.2025.101960_bib46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41575-020-00378-1","article-title":"Current and emerging therapies for coeliac disease","volume":"18","author":"Kivela","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.smim.2025.101960_bib47","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2468-1253(19)30265-1","article-title":"Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study","volume":"4","author":"Cellier","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.smim.2025.101960_bib48","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1053\/j.gastro.2022.07.086","article-title":"AGA clinical practice update on management of refractory celiac disease: expert review","volume":"163","author":"Green","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2025.101960_bib49","article-title":"Budesonide induces favourable histologic and symptomatic recovery in patients with non-responsive and refractory coeliac disease when given in an open capsule format","author":"Saitta","year":"2024","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.smim.2025.101960_bib50","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/cea.12153","article-title":"Baked egg food challenges - clinical utility of skin test to baked egg and ovomucoid in children with egg allergy","volume":"43","author":"Tan","year":"2013","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.smim.2025.101960_bib51","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jaci.2008.05.043","article-title":"Tolerance to extensively heated milk in children with cow's milk allergy","volume":"122","author":"Nowak-Wegrzyn","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib52","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/j.jaip.2024.06.016","article-title":"The safety and efficacy of baked egg and milk dietary advancement therapy: a systematic review and meta-analysis","volume":"12","author":"Anagnostou","year":"2024","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.smim.2025.101960_bib53","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1542\/peds.2007-0350","article-title":"Clinical characteristics of peanut-allergic children: recent changes","volume":"120","author":"Green","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.smim.2025.101960_bib54","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.smim.2025.101960_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2021.100512","article-title":"The peanut allergy burden study: impact on the quality of life of patients and caregivers","volume":"14","author":"Nowak-Wegrzyn","year":"2021","journal-title":"World Allergy Organ J."},{"key":"10.1016\/j.smim.2025.101960_bib56","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2012-1180","article-title":"Child and parental reports of bullying in a consecutive sample of children with food allergy","volume":"131","author":"Shemesh","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.smim.2025.101960_bib57","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/jpepsy\/jsab099","article-title":"Food allergy-related bullying among children and adolescents","volume":"47","author":"Cooke","year":"2022","journal-title":"J. Pediatr. Psychol."},{"key":"10.1016\/j.smim.2025.101960_bib58","unstructured":"U.S. FDA. Food Allergen Labeling and Consumer Protection Act of 2004 (FALCPA). 2004."},{"key":"10.1016\/j.smim.2025.101960_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2024.100972","article-title":"Time to ACT-UP: Update on precautionary allergen labelling (PAL)","volume":"17","author":"Turner","year":"2024","journal-title":"World Allergy Organ J."},{"key":"10.1016\/j.smim.2025.101960_bib60","unstructured":"FDA. Palforzia, 2024."},{"key":"10.1016\/j.smim.2025.101960_bib61","unstructured":"FDA. FDA Approves First Medication to Help Reduce Allergic Reactions to Multiple Foods After Accidental Exposure. 2024."},{"key":"10.1016\/j.smim.2025.101960_bib62","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.smim.2025.101960_bib63","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.smim.2025.101960_bib64","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jaip.2022.11.036","article-title":"Omalizumab in IgE-mediated food allergy: a systematic review and meta-analysis","volume":"11","author":"Zuberbier","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.smim.2025.101960_bib65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11882-024-01132-2","article-title":"A review of shared decision-making, published protocols, and post-desensitization strategies in oral immunotherapy (OIT)","volume":"24","author":"Laubach","year":"2024","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.smim.2025.101960_bib66","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1126\/science.1074129","article-title":"Structural basis for gluten intolerance in celiac sprue","volume":"297","author":"Shan","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.smim.2025.101960_bib67","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1053\/gast.2002.35381","article-title":"Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues","volume":"123","author":"Arentz-Hansen","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2025.101960_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/nu12072095","article-title":"Gluten degrading enzymes for treatment of celiac disease","volume":"12","author":"Wei","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.smim.2025.101960_bib69","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.foodres.2016.11.021","article-title":"Novel approaches for enzymatic gluten degradation to create high-quality gluten-free products","volume":"110","author":"Scherf","year":"2018","journal-title":"Food Res. Int."},{"key":"10.1016\/j.smim.2025.101960_bib70","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1053\/j.gastro.2022.07.071","article-title":"Latiglutenase protects the mucosa and attenuates symptom severity in patients with celiac disease exposed to a gluten challenge","volume":"163","author":"Murray","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2025.101960_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/foods10102351","article-title":"Current status and perspectives on the application of CRISPR\/Cas9 gene-editing system to develop a low-gluten, non-transgenic wheat variety","volume":"10","author":"Verma","year":"2021","journal-title":"Foods"},{"key":"10.1016\/j.smim.2025.101960_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/nu13124548","article-title":"Oral consumption of bread from an RNAi wheat line with strongly silenced gliadins elicits no immunogenic response in a pilot study with celiac disease patients","volume":"13","author":"Guzman-Lopez","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.smim.2025.101960_bib73","doi-asserted-by":"crossref","DOI":"10.1093\/jxb\/erae376","article-title":"CRISPR\/Cas9-mediated multiplex gene editing of gamma and omega gliadins, paving the way for gliadin-free wheat","author":"Sanchez-Leon","year":"2024","journal-title":"J. Exp. Bot."},{"key":"10.1016\/j.smim.2025.101960_bib74","first-page":"11","article-title":"Gluten free wheat: are we there?","author":"Garcia-Molina","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.smim.2025.101960_bib75","article-title":"Blurring the picture in leaky gut research: how shortcomings of zonulin as a biomarker mislead the field of intestinal permeability","author":"Massier","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.smim.2025.101960_bib76","article-title":"Lack of relationship of AT1001 to zonulin and prehaptoglobin-2: clinical implications","author":"Sollid","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.smim.2025.101960_bib77","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/med.21753","article-title":"Emerging roles of SIRT6 in human diseases and its modulators","volume":"41","author":"Liu","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.smim.2025.101960_bib78","article-title":"Safety, clinical activity, pharmacodynamics, and pharmacokinetics of IMU-856, a SIRT6 modulator, in coeliac disease: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial","author":"Daveson","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.smim.2025.101960_bib79","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2032441","article-title":"A randomized trial of a transglutaminase 2 inhibitor for celiac disease","volume":"385","author":"Schuppan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2025.101960_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-44083-4","article-title":"Characterizations of a neutralizing antibody broadly reactive to multiple gluten peptide:HLA-DQ2.5 complexes in the context of celiac disease","volume":"14","author":"Okura","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2025.101960_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110259","article-title":"A bispecific antibody targeting HLA-DQ2.5-gluten peptides potently blocks gluten-specific T cells induced by gluten ingestion in patients with celiac disease","volume":"264","author":"Hardy","year":"2024","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3001012","article-title":"Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease","volume":"2","author":"Tye-Din","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.smim.2025.101960_bib83","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1172\/JCI98819","article-title":"Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease","volume":"128","author":"Risnes","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2025.101960_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.665756","article-title":"The evolving landscape of biomarkers in celiac disease: leading the way to clinical development","volume":"12","author":"Smithson","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib85","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-024-00895-3","article-title":"Tolerance-inducing therapies in coeliac disease - mechanisms, progress and future directions","volume":"21","author":"Sollid","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.smim.2025.101960_bib86","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S2468-1253(22)00428-9","article-title":"Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study","volume":"8","author":"Tye-Din","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.smim.2025.101960_bib87","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S2468-1253(17)30110-3","article-title":"Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies","volume":"2","author":"Goel","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.smim.2025.101960_bib88","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/apt.15477","article-title":"Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease","volume":"50","author":"Tye-Din","year":"2019","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.smim.2025.101960_bib89","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/cei.13578","article-title":"Whole blood interleukin-2 release test to detect and characterize rare circulating gluten-specific T cell responses in coeliac disease","volume":"204","author":"Anderson","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib90","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/apt.15551","article-title":"Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease","volume":"51","author":"Daveson","year":"2020","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.smim.2025.101960_bib91","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/j.gastro.2021.03.014","article-title":"TAK-101 nanoparticles induce gluten-specific tolerance in celiac disease: a randomized, double-blind, placebo-controlled study","volume":"161","author":"Kelly","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2025.101960_bib92","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S2468-1253(23)00107-3","article-title":"Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial","volume":"8","author":"Murray","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.smim.2025.101960_bib93","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/all.12314","article-title":"Acute and long-term management of food allergy: systematic review","volume":"69","author":"de Silva","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.smim.2025.101960_bib94","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.2165\/11640800-000000000-00000","article-title":"Sublingual vs oral immunotherapy for food allergy: identifying the right approach","volume":"72","author":"Narisety","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.smim.2025.101960_bib95","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2500\/jfa.2022.4.220026","article-title":"Sublingual immunotherapy as an option for effective food allergy treatment","volume":"4","author":"Bajowala","year":"2022","journal-title":"J. Food Allergy"},{"key":"10.1016\/j.smim.2025.101960_bib96","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11882-014-0486-9","article-title":"Sublingual (SLIT) versus oral immunotherapy (OIT) for food allergy","volume":"14","author":"McGowan","year":"2014","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.smim.2025.101960_bib97","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-065X.2011.01028.x","article-title":"Anaphylaxis: a history with emphasis on food allergy","volume":"242","author":"Boden","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.smim.2025.101960_bib98","article-title":"Epicutaneous immunotherapy for the treatment of peanut allergy","author":"Ravindran","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.smim.2025.101960_bib99","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jamapediatrics.2023.6630","article-title":"Varying doses of epicutaneous immunotherapy with viaskin milk vs placebo in children with cow's milk allergy: a randomized clinical trial","volume":"178","author":"Petroni","year":"2024","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.smim.2025.101960_bib100","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/all.13479","article-title":"Gata3 hypermethylation and Foxp3 hypomethylation are associated with sustained protection and bystander effect following epicutaneous immunotherapy in peanut-sensitized mice","volume":"74","author":"Mondoulet","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.smim.2025.101960_bib101","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1056\/NEJMoa2212895","article-title":"Phase 3 trial of epicutaneous immunotherapy in toddlers with peanut allergy","volume":"388","author":"Greenhawt","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2025.101960_bib102","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaci.2020.06.028","article-title":"Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results","volume":"146","author":"Fleischer","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib103","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jaip.2020.08.017","article-title":"Sustained unresponsiveness to peanut after long-term peanut epicutaneous immunotherapy","volume":"9","author":"Brown-Whitehorn","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.smim.2025.101960_bib104","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2468-1253(19)30264-X","article-title":"Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study","volume":"4","author":"Lahdeaho","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.smim.2025.101960_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(24)00940-5","article-title":"CALY-002, an anti-IL-15 antibody, prevents gluten challenge induced mucosal damage and inflammation: results from a phase 1A\/B study","volume":"166","author":"Schumann","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2025.101960_bib106","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/j.gastro.2019.10.006","article-title":"Identification of a gammac receptor antagonist that prevents reprogramming of human tissue-resident cytotoxic T cells by IL15 and IL21","volume":"158","author":"Ciszewski","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2025.101960_bib107","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41591-019-0403-9","article-title":"Distinct phenotype of CD4(+) T cells driving celiac disease identified in multiple autoimmune conditions","volume":"25","author":"Christophersen","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2025.101960_bib108","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/all.15591","article-title":"Dupilumab has a profound effect on specific-IgE levels of several food allergens in atopic dermatitis patients","volume":"78","author":"Spekhorst","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.smim.2025.101960_bib109","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jaci.2012.05.039","article-title":"Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy","volume":"130","author":"Savage","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2024.1409342","article-title":"Omalizumab for the reduction of allergic reactions to foods: a narrative review","volume":"5","author":"Ghouri","year":"2024","journal-title":"Front Allergy"},{"key":"10.1016\/j.smim.2025.101960_bib111","doi-asserted-by":"crossref","first-page":"12","DOI":"10.32481\/djph.2023.11.004","article-title":"CAR T cells for treating severe atopic allergic diseases","volume":"9","author":"Dudek","year":"2023","journal-title":"Dela J. Public Health"},{"key":"10.1016\/j.smim.2025.101960_bib112","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1053\/j.gastro.2018.12.013","article-title":"Plasma cells are the most abundant gluten peptide MHC-expressing cells in inflamed intestinal tissues from patients with celiac disease","volume":"156","author":"Hoydahl","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2025.101960_bib113","doi-asserted-by":"crossref","DOI":"10.1093\/jimmun\/vkaf008","article-title":"Can autoimmune disease be cured by deep CD19+ cell depletion?","author":"Suan","year":"2025","journal-title":"J. Immunol"},{"key":"10.1016\/j.smim.2025.101960_bib114","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/imr.12524","article-title":"New checkpoints in cancer immunotherapy","volume":"276","author":"Ni","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.smim.2025.101960_bib115","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaci.2022.02.024","article-title":"A mouse model of the LEAP study reveals a role for CTLA-4 in preventing peanut allergy induced by environmental peanut exposure","volume":"150","author":"Krempski","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib116","article-title":"Abatacept to induce remission of peanut allergy during oral immunotherapy (ATARI): protocol for a phase 2a randomized controlled trial","volume":"10","author":"Braun","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.smim.2025.101960_bib117","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jaci.2022.06.012","article-title":"Modulation of IL-4\/IL-13 cytokine signaling in the context of allergic disease","volume":"150","author":"Shankar","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib118","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/intimm\/12.2.123","article-title":"Janus kinase 3 (Jak3) is essential for common cytokine receptor gamma chain (gamma(c))-dependent signaling: comparative analysis of gamma(c), Jak3, and gamma(c) and Jak3 double-deficient mice","volume":"12","author":"Suzuki","year":"2000","journal-title":"Int. Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2024.05.022","article-title":"Enduring clinical remission in refractory celiac disease type II with tofacitinib: an open-label clinical study","author":"Dieckman","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.smim.2025.101960_bib120","article-title":"JAK1 inhibition with abrocitinib decreases allergen-specific basophil and T-cell activation in pediatric peanut allergy","volume":"2","author":"Ramsey","year":"2023","journal-title":"J. Allergy Clin. Immunol. Glob."},{"key":"10.1016\/j.smim.2025.101960_bib121","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.anai.2024.03.002","article-title":"Bruton's tyrosine kinase inhibition for the treatment of allergic disorders","volume":"133","author":"Lin","year":"2024","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib122","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.jaci.2017.12.987","article-title":"Short-term ibrutinib therapy suppresses skin test responses and eliminates IgE-mediated basophil activation in adults with peanut or tree nut allergy","volume":"141","author":"Dispenza","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2024.1438252","article-title":"Gut microbiome features in pediatric food allergy: a scoping review","volume":"5","author":"Farnetano","year":"2024","journal-title":"Front. Allergy"},{"key":"10.1016\/j.smim.2025.101960_bib124","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.anai.2024.03.010","article-title":"Gut microbiome in the first 1000 days and risk for childhood food allergy","volume":"133","author":"Davis","year":"2024","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2024.1473352","article-title":"Probiotics and other adjuvants in allergen-specific immunotherapy for food allergy: a comprehensive review","volume":"5","author":"Mennini","year":"2024","journal-title":"Front. Allergy"},{"key":"10.1016\/j.smim.2025.101960_bib126","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.celrep.2016.05.047","article-title":"Dietary fiber and bacterial SCFA enhance oral tolerance and protect against food allergy through diverse cellular pathways","volume":"15","author":"Tan","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.smim.2025.101960_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/cells12010184","article-title":"Probiotics mechanism of action on immune cells and beneficial effects on human health","volume":"12","author":"Mazziotta","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.smim.2025.101960_bib128","unstructured":"Draft Guidance. Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet. US Food and Drug Administration: Available at: \u3008https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/celiac-disease-developing-drugs-adjunctive-treatment-gluten-free-diet\u3009; 2022."},{"key":"10.1016\/j.smim.2025.101960_bib129","first-page":"294","article-title":"Development of celiac disease therapeutics: the sixth gastroenterology regulatory endpoints and the advancement of therapeutics workshop","volume":"2","author":"Lavine","year":"2022","journal-title":"GastroHep"},{"key":"10.1016\/j.smim.2025.101960_bib130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2023.08.051","article-title":"Standardizing randomized controlled trials in celiac disease: an international multidisciplinary appropriateness study","volume":"166","author":"Lebwohl","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2025.101960_bib131","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1053\/j.gastro.2022.06.086","article-title":"Regulatory and clinical expert perspective of the 2022 FDA draft guidance \"celiac disease: developing drugs for adjunctive treatment to a gluten-free diet\"","volume":"164","author":"Goldkind","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2025.101960_bib132","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jval.2019.07.018","article-title":"Concepts and instruments for patient-reported outcome assessment in celiac disease: literature review and experts","volume":"23","author":"Clifford","year":"2020","journal-title":"Perspect. Value Health"},{"key":"10.1016\/j.smim.2025.101960_bib133","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/apt.13703","article-title":"Systematic review: patient-reported outcome measures in coeliac disease for regulatory submissions","volume":"44","author":"Canestaro","year":"2016","journal-title":"Aliment Pharm. Ther."},{"key":"10.1016\/j.smim.2025.101960_bib134","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/gutjnl-2016-312762","article-title":"Disease activity indices in coeliac disease: systematic review and recommendations for clinical trials","volume":"67","author":"Hindryckx","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.smim.2025.101960_bib135","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/apt.17942","article-title":"Development and validation of a brain fog scale for coeliac disease","volume":"59","author":"Knowles","year":"2024","journal-title":"Aliment Pharm. Ther."},{"key":"10.1016\/j.smim.2025.101960_bib136","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1053\/j.gastro.2016.11.004","article-title":"No difference between latiglutenase and placebo in reducing villous atrophy or improving symptoms in patients with symptomatic celiac disease","volume":"152","author":"Murray","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2025.101960_bib137","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jaci.2012.10.017","article-title":"Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report","volume":"130","author":"Sampson","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib138","unstructured":"FDA. Biomarker-driven Drug Development for Allergic Diseases and Asthma; Public Workshop. 2024."},{"key":"10.1016\/j.smim.2025.101960_bib139","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/1744666X.2021.2006636","article-title":"Emergence of an adaptive immune paradigm to explain celiac disease: a perspective on new evidence and implications for future interventions and diagnosis","volume":"18","author":"Anderson","year":"2022","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.smim.2025.101960_bib140","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1053\/j.gastro.2008.11.040","article-title":"Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study","volume":"136","author":"Kurppa","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2025.101960_bib141","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jpeds.2010.02.070","article-title":"Celiac disease without villous atrophy in children: a prospective study","volume":"157","author":"Kurppa","year":"2010","journal-title":"J. Pediatr."},{"key":"10.1016\/j.smim.2025.101960_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.661622","article-title":"A sensitive whole blood assay detects antigen-stimulated cytokine release from CD4+ T cells and facilitates immunomonitoring in a phase 2 clinical trial of Nexvax2 in coeliac disease","volume":"12","author":"Hardy","year":"2021","journal-title":"Front. Immunol."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532325000326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532325000326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T15:05:31Z","timestamp":1749222331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532325000326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":141,"alternative-id":["S1044532325000326"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2025.101960","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune therapies in coeliac disease and food allergies: Advances, challenges, and opportunities","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2025.101960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101960"}}